Given the central role of AMPK in metabolism and the plethora of down-stream metabolic processes that are regulated by this kinase, AMPK has attracted global attention as a potential target for treating metabolic diseases such as obesity, Type 2 diabetes and cancer. Here, PRKAA2 is linked to obesity due to melanocortin 4 receptor deficiency.